Gynae BT 2017

PORTEC-1: 15-year outcomes for HIR patients

Locoregional Recurrence

Failure Free Survival

Treatment arm Failure free survival - HIR

Treatment arm Locoregional relapse - HIR

100

30

N 192 196

F 12 39 P <.001

RT no RT Logrank

no RT

75

20

RT

50

75% vaginal recurrences

no RT

RT

25

Cumulative percentage

N 192 196

F 104 107 P =0.48

RT no RT Logrank

0

0

years

0

5

10

15

years

0

5

10

15

At risk: 192 196

At risk: 192 196

RT no RT

146 134

112 105

31 26

RT no RT

147 136

113 106

31 27

Creutzberg et al, ASTRO 2009, IJROBP 2011